97国产精品人人爽人人做 I 日本r级电影在线观看 I 污91视频 I 性中国xxx极品hd I 偷偷在线观看免费播放电视剧大全 I 番号动态图 I 日韩小视频网站 I 国产色资源 I 国产精品乱码一区二区三区 I av在线不卡电影 I av电影站 I 亚洲成人黄色av I 丁香花电影版免费观看第二季 I 麻豆午夜视频 I av在线色 I 日日夜夜欧美 I a视频在线看 I 日韩一区欧美一区 I 毛片美女 I 97精品国产露脸对白 I 久久免费视频一区二区 I 夜夜嗨av色一区二区不卡 I 亚洲黄一区二区 I 成人毛片18女人 I 四虎8848a I 欧美有码在线视频 I 极品尤物视频在线观看 I 国模欢欢大尺度啪啪 I 新版资源中文在线www I 亚洲国产成av人天堂无码 I 国产成久久免费精品av片 I 极品少妇小泬50pthepon I 日本中文字幕中出在线 I 色综合天天狠 天天透天天伊人 I 成人免费高清观看 I 精品亚洲韩国一区二区三区 I 91精品夜夜 I 成人白浆超碰人人人人 I 亚洲青青草原男人的天堂

×

NHU Holding Group Ranks Among Top 500 in Both R&D Investment and Invention Patents for 2025

Time:2025-10-09

Recently, the All-China Federation of Industry and Commerce released the “Top 500 Private Enterprises by Invention Patents 2025” and “Top 500 Private Enterprises by R&D Investment 2025”. NHU Holding Group once again earned a place on both prestigious lists.

Our robust R&D capabilities and solid patent portfolio have secured our continued recognition, highlighting our innovative vitality and strong growth momentum within the industry. This dual achievement reflects our long-term dedication to our core business, our steadfast focus on industrial development, and our active alignment with national strategies. It also reaffirms our pioneering spirit and unwavering commitment to technological innovation and intellectual property protection.

For more than three decades, NHU has been deeply engaged in fine chemicals, pharmaceuticals, equipment, and education, continuously strengthening the innovation, industrial, and value chains. Each year, we invest heavily in cutting-edge technology research and product development. Over the past five years, we have invested 5.506 billion yuan in R&D, averaging over 5% of our annual sales revenue.

In fine chemicals, NHU has achieved breakthroughs in key technologies that have long constrained the development of vitamin E, vitamin A, PPS, and methionine. In pharmaceuticals, we have established strong product portfolios in cardiovascular and diabetes therapeutics, while advancing research into innovative small nucleic acid drugs.

By the end of 2024, NHU held 1,020 valid domestic patents and 129 valid international patents. In addition, research outcomes from our university collaborations have received one China Patent Gold Award and one Silver Award, reinforcing our commitment to building a solid foundation for sustainable development.

Back To List

Learn more